Réaction #89228

ord-274f8001d8f648d7b6aabdd941b2fcf3

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Mode opératoire

The title compound was prepared following the same general protocol as described in Example A1, using 5-methyl-2-(thiazol-5-yl)benzoic acid and 5-chloro-N-(((2S,3R)-3-methylpiperidin-2-yl)methyl)benzo[d]oxazol-2-amine. ESI-MS (m/z): 481 [M+1]+.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US09440982B2uspto-grants-2016_09